CA
NZ
UK
AU
IND
US
Angel Studios, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, reporting third-quarter and nine-month financial results for NYSE:ANGX.
The Beachbody Company, Inc. filed a Form 10-Q with the SEC on November 10, 2026, covering the quarterly period ended September 30, 2026, reporting net income of $6,951 thousand for the nine months ended September 30, 2026, compared to a net loss of $8,079 …
Mount Logan Capital Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the U.S. Securities and Exchange Commission, disclosing condensed consolidated financial position data and operational details as of that date.
Autolus Therapeutics plc filed a voluntary quarterly report on Form 10-Q with the SEC on November 10, 2026, covering the three and nine months ended September 30, 2026, disclosing financial results and operational updates for the period.
Koru Medical Systems, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 10, 2026, reporting a return to quarterly net income alongside continued nine-month revenue growth.
KORU Medical Systems, Inc. filed a Form 8-K on November 10, 2026, announcing its financial results for the third fiscal quarter ended September 30, 2026, and updating financial guidance for the fiscal year ended December 31, 2026.
SANUWAVE Health, Inc. filed its quarterly report on Form 10-Q with the SEC on November 10, 2026, covering the period ended September 30, 2026, disclosing condensed consolidated balance sheet figures including a decline in cash and accounts receivable from year-end 2025 levels.
Hyliion Holdings Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 10, 2026, reporting a significant increase in research and development services revenue alongside a reduced net loss compared to the prior-year …
Gevo, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, reporting a third-quarter net profit alongside a substantial nine-month accumulated loss driven largely by asset impairment charges.
PetMed Express, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 10, 2026, reporting condensed consolidated balance sheet data that shows retained earnings swinging to a deficit of $3,316 thousand from a positive $9,263 thousand …
Please wait processing your request...